Literature DB >> 24381069

Re: Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.

Lisa M Hess1, Gebra Carter, Lee Smolen, Lee Bowman, Philipp von Hohnhorst, Chris Seagle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24381069     DOI: 10.1093/jnci/djt370

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  1 in total

Review 1.  The economic considerations and implications of the stratification of future oncology therapeutics.

Authors:  Maria Gazouli; Kyriakos Souliotis
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.